I did some calculating, and I get it....so this outfit touts the top 5 Pharma Stocks on the TSX but only includes those with Market Caps between $50 million and $500 million.
Resverlogix started 2018 with a MC of around $376 million, well within the parameters, but now has performed so well the MC is over $584 million....so its not considered as being one of the top 5 biotechs.
Dumb.